Pure Global AI
China flag

China medical device registration timeline

Source-linked clocks

National Medical Products Administration (NMPA) review clocks and end-to-end planning ranges, using the 3-class (I, II, III) classification system.

3 pathways3 of 3 clocks verifiedvalidity 5 years (Class II & III), Unlimited (Class I)MDSAP not acceptedreviewed 2026-08-30gov.cn
Class / pathwayReview clockPlanning totalWith prior approvalProvenance
Class I(Filing/Recordation (备案) — no review, no fee)

Zero days is the published position, not an estimate: the NMPA service item classifies the filing as an 即办件 and states that where the materials are complete and in the required form the filing is made 当场 — on the spot — against a sealed 备案凭证

Regulation No. 739 art. 15 completes the filing on submission of conforming materials and obliges the authority to publish the filing within 5 working days of receipt, which is a publication duty rather than a review period

Deficient materials draw a single consolidated notice of everything needing correction, so the elapsed time in practice is dossier preparation under Announcement No. 62 of 2022, which is what the realistic range measures

No fee, and no expiry; filed with the municipal authority for a domestic device and with NMPA for an imported one, through a designated Chinese legal person

0 days2-4 months—Verified
Class II(Provincial Registration)

Technical review 60 days under the parallel Order No. 47 Art. 92 structure; statutory administrative decision 20 working days; promised acceptance 5 working days

In-country testing required (~6 months)

Clinical often exempted

4 months1-1.5 years—Verified
Class III(NMPA Registration)

Class III technical review: 90 days for registration/change/renewal, 60 days after applicant supplement (Order No. 47 Art. 92); statutory administrative decision 20 working days; promised acceptance 5 working days

IVD technical review (Order No. 48 Art. 92): Class II IVD 60 days, Class III IVD 90 days, plus supplement clocks

Clinical trials often required

In-country testing 6-9 months

5-6 months2-3 years1.2-1.7 yearsVerified
Review clocks exclude applicant hold time · planning totals are estimates

Planning steps and estimates; these are not regulator deadlines.

China Medical Device Registration Process

Step-by-step NMPA registration process. Total estimated timeline: 2-4 months.

Step 1: Device Classification

2-4 weeks

Classify device under NMPA rules (Class I, II, or III). Class III requires full registration.

Step 2: In-Country Testing

3-6 months

Testing at NMPA-designated Chinese laboratories required for most Class II/III devices.

Step 3: Clinical Trial (if required)

12-24 months

Many Class II/III devices require Chinese clinical trials. Can take 12-24 months.

Step 4: Appoint Agent

2-4 weeks

Foreign manufacturers must appoint a Chinese agent/legal representative for submissions.

Step 5: NMPA Application

1-2 weeks

Submit registration dossier to NMPA/CFDA. Documentation must be in Chinese.

Step 6: NMPA Review

12-18 months

NMPA conducts technical review. Multiple Q&A rounds common. Average 12-18 months for Class III.

Step 7: Registration Certificate

2-4 weeks

NMPA issues registration certificate. Valid 5 years with annual renewal requirements.

Summary: The China medical device registration process through National Medical Products Administration (NMPA) consists of 7 main steps: Device Classification → In-Country Testing → Clinical Trial (if required) → Appoint Agent → NMPA Application → NMPA Review → Registration Certificate.
Expedited pathways
Priority Review (Innovative Devices)6-12 months faster

Expedited review for rare diseases, malignant tumors, pediatric devices

Eligibility: Significant clinical advantage, No alternative treatment, Innovative technology

Hainan Boao Pilot Zone4 months vs 3-5 years standard

Fast-track initial use with real-world data collection

Eligibility: Approved overseas (FDA, CE), Not yet registered in China nationally

Greater Bay Area (GBA) ConnectAccess to 9 major cities

Fast-track for Hong Kong/Macau approved devices

Eligibility: Hong Kong or Macau approval

Prior approval recognition
FDA 510(k)/PMARequired as home country approvalRequired documentation
EU CE MarkRequired as home country approvalRequired documentation
Foreign Clinical DataMay be accepted if China GCP compliant12-18 months if accepted
Key requirements
  • China Agent (mandatory for foreign manufacturers)
  • In-country testing at NMPA-certified lab
  • Chinese labeling and IFU
  • Clinical trial (Class III, unless exempted)
  • GMP compliance (Class II & III)
  • Clinical-trial approval review: 60 days for the trial application, 40 days after supplement (Order No. 47 Art. 92)
  • The registration clock is built from four published segments, which is why the class figures are sums rather than single periods: 5 working days promised for acceptance, 3 working days to transfer the file to the technical review centre, the Order No. 47 Art. 92 technical review, then 20 working days under Regulation No. 739 art. 18 for the administrative decision
  • Two exclusions sit outside the review clock: the applicant has one year to complete a supplement request, and the 15-day objection window against a proposed negative opinion under Order No. 47 Art. 57 is expressly not counted
  • Approved registrations are published within 5 working days (Regulation No. 739 art. 18), and Class I filings within 5 working days of receipt (art. 15)
Primary regulator sources

Reviewed 2026-08-30. End-to-end totals remain planning estimates.

Keep researching this market
View the China resource hub →
Compare timeline across all countries →
Source-linked review clocks verified against NMPA publications · full review 2026-08-30 · row IDs are stable — cite as registration-timeline:china:class-i